Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Danny Rischin

9PUBLICATIONS

97CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (9)

Sort by Publication Date:

|Dec 22, 2025

INDUCE-3: A Randomized Phase II/III Study of First-line Feladilimab plus Pembrolizumab in Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma.

Danny Rischin, Aaron R Hansen, Ezra E W Cohen

|Aug 27, 2025

Impact of Adjuvant Cemiplimab in High-Risk Cutaneous Squamous Cell Carcinoma.

Annette M Lim, Sandro Porceddu, Danny Rischin

|Aug 11, 2025

First-in-human phase 1 study of the ICOS agonist feladilimab on patients with advanced solid tumors.

Michele Maio, Victor Moreno, Juan Martin-Liberal

|May 22, 2025

Randomized Phase Ib Clinical Trial of DB-020 Intratympanic Injections to Reduce High-Dose Cisplatin Ototoxicity.

Benedict J Panizza, Stephen John O'Leary, Christopher David Hart

|Apr 29, 2025

INTERLINK-1: A Phase III, Randomized, Placebo-Controlled Study of Monalizumab plus Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma.

Jérôme Fayette, Lisa Licitra, Kevin Harrington

|Mar 12, 2024

High response rate with extended dosing of cemiplimab in advanced cutaneous squamous cell carcinoma.

Danny Rischin, Brett G M Hughes, Nicole Basset-Séguin

Pageof 2

Frequent Collaborators

2 joint publications

Kevin J Harrington

2 joint publications

Robert L Ferris

2 joint publications

Annette M Lim

2 joint publications

Robert I Haddad

2 joint publications

Lisa Licitra

2 joint publications

Makoto Tahara

2 joint publications

Marc Ballas

2 joint publications

Catherine Ellis

2 joint publications

Michael J Chisamore

1 joint publications

Jeremy D Waight

Frequent Collaborators

2 joint publications

Kevin J Harrington

2 joint publications

Robert L Ferris

2 joint publications

Annette M Lim

2 joint publications

Robert I Haddad

Top Related Videos

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Published on : Jun 02, 2023

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on : Feb 12, 2017

A Human Peripheral Blood Mononuclear Cell (PBMC) Engrafted Humanized Xenograft Model for Translational Immuno-oncology (I-O) Research

A Human Peripheral Blood Mononuclear Cell (PBMC) Engrafted Humanized Xenograft Model for Translational Immuno-oncology (I-O) Research

Published on : Aug 15, 2019

See more related videos

Top Related Videos

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Published on : Jun 02, 2023

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on : Feb 12, 2017

A Human Peripheral Blood Mononuclear Cell (PBMC) Engrafted Humanized Xenograft Model for Translational Immuno-oncology (I-O) Research

A Human Peripheral Blood Mononuclear Cell (PBMC) Engrafted Humanized Xenograft Model for Translational Immuno-oncology (I-O) Research

Published on : Aug 15, 2019

See more related videos